CNTA (STOCKS)
Centessa Pharmaceuticals plc American Depositary Shares
$39.760000
+0.040000 (+0.10%)
Prev close: $39.720000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Mario Alberto Accardi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6,150.48M
- Employees
- 114
- P/E (TTM)
- -22.40
- P/B (TTM)
- 12.61
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Income/Loss | -$256.69M |
| Income/Loss From Continuing Operations After Tax | -$250.64M |
| Income/Loss From Continuing Operations Before Tax | -$249.37M |
| Income Tax Expense/Benefit | $1.27M |
| Income Tax Expense/Benefit, Deferred | $2.34M |
| Net Income/Loss | -$250.64M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$250.64M |
| Net Income/Loss Available To Common Stockholders, Basic | -$250.64M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.79 |
| Diluted Earnings Per Share | -$1.79 |
| Basic Average Shares | 423,479,195 |
| Diluted Average Shares | 423,479,195 |
| Assets | $641.76M |
| Current Assets | $348.68M |
| Noncurrent Assets | $293.08M |
| Fixed Assets | $722.00K |
| Other Non-current Assets | $292.36M |
| Liabilities | $154.42M |
| Current Liabilities | $36.57M |
| Accounts Payable | $10.66M |
| Wages | $3.09M |
| Other Current Liabilities | $22.83M |
| Noncurrent Liabilities | $117.84M |
| Long-term Debt | $110.44M |
| Other Non-current Liabilities | $7.40M |
| Equity | $487.35M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $487.35M |
| Liabilities And Equity | $641.76M |
| Net Cash Flow From Operating Activities | -$208.80M |
| Net Cash Flow From Operating Activities, Continuing | -$208.80M |
| Net Cash Flow From Investing Activities | -$153.44M |
| Net Cash Flow From Investing Activities, Continuing | -$153.44M |
| Net Cash Flow From Financing Activities | $318.91M |
| Net Cash Flow From Financing Activities, Continuing | $318.91M |
| Exchange Gains/Losses | $1.25M |
| Net Cash Flow | -$42.07M |
| Net Cash Flow, Continuing | -$43.32M |
| Comprehensive Income/Loss | -$251.31M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$251.31M |
| Other Comprehensive Income/Loss | -$251.31M |
| Other Comprehensive Income/Loss Attributable To Parent | -$667.00K |